Latest news with #Blink
Business Wire
a day ago
- Business
- Business Wire
Bausch + Lomb Announces Second-Quarter 2025 Results
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its second-quarter 2025 financial results. 'Our continued growth speaks to the breadth and depth of our portfolio and is driven by a mix of hero products and a steady stream of new introductions around the world,' said Brent Saunders, chairman and CEO, Bausch + Lomb. 'Our robust pipeline represents the future of the company, and we're excited to showcase potential gamechangers at our November 13 investor day.' Select Company Highlights Resumed full production of all enVista ® platform IOLs following return to market platform IOLs following return to market Reached approximately $1 billion in trailing 12-month revenue across the dry eye portfolio Drove broad-based growth in Vision Care, led by key contact lens franchises – Daily SiHy, ULTRA ® monthly, and Biotrue ® ONEday – and strong performance from consumer brands, including ARTELAC ® , LUMIFY ® and Blink ® monthly, and Biotrue ONEday – and strong performance from consumer brands, including ARTELAC , LUMIFY and Blink Successfully executed refinancing transaction thereby extending maturity profile Second-Quarter 2025 Revenue Performance Total reported revenue was $1.278 billion for the second quarter of 2025, as compared to $1.216 billion in the second quarter of 2024, an increase of $62 million, or 5%. Excluding the favorable impact of foreign exchange of $21 million, revenue increased by approximately 3% on a constant currency1 basis compared to the second quarter of 2024. Revenue by segment was as follows: Second-Quarter 2025 (in millions) Three Months Ended June 30 Reported Change Reported Change Change at Constant Currency1 (non-GAAP) 2025 2024 Total Bausch + Lomb Revenue $1,278 $1,216 $62 5% 3% Vision Care $753 $697 $56 8% 6% Surgical $216 $209 $7 3% 1% Pharmaceuticals $309 $310 ($1) 0% (1%) Expand Vision Care Segment Vision Care segment revenue was $753 million for the second quarter of 2025, as compared to $697 million for the second quarter of 2024, an increase of $56 million, or 8%. Excluding the favorable impact of foreign exchange of $14 million, segment revenue increased on a constant currency1 basis by approximately 6% compared to the second quarter of 2024, driven by sales from the dry eye portfolio and LUMIFY in the consumer eye care business and SiHy Daily lenses, ULTRA monthly and Biotrue ONEday in the contact lens business. Surgical Segment Surgical segment revenue was $216 million for the second quarter of 2025, as compared to $209 million for the second quarter of 2024, an increase of $7 million, or 3%. Excluding the favorable impact of foreign exchange of $5 million, segment revenue increased on a constant currency1 basis by approximately 1% compared to the second quarter of 2024, primarily driven by growth in consumables, partially offset by the voluntary recall of certain enVista IOL products. Pharmaceuticals Segment Pharmaceuticals segment revenue was $309 million for the second quarter of 2025, as compared to $310 million for the second quarter of 2024, a decrease of $1 million. Excluding the favorable impact of foreign exchange of $2 million, segment revenue decreased on a constant currency1 basis by approximately 1% compared to the second quarter of 2024, driven by a decline in the U.S. Generics business and gross-to-net pricing pressure, primarily attributable to XIIDRA®, partially offset by increased sales of MIEBO and revenue growth in International Pharmaceuticals. Operating Results Operating loss was $11 million for the second quarter of 2025, as compared to operating income of $26 million for the second quarter of 2024, a decrease of $37 million. The change was largely due to higher selling and advertising and promotion costs, primarily attributable to MIEBO, a one-time impact related to the voluntary recall of certain enVista IOL products, product mix and currency impact. Net Loss Net loss attributable to Bausch + Lomb Corporation for the second quarter of 2025 was $62 million, as compared to $151 million for the second quarter of 2024, a favorable change of $89 million. The change was mainly driven by a decrease in income taxes, partially offset by financing fees from the refinancing debt transaction and operating results. Adjusted net income attributable to Bausch + Lomb Corporation (non-GAAP)1 for the second quarter of 2025 was $25 million, as compared to adjusted net income of $45 million for the second quarter of 2024, a decrease of $20 million. Cash Flow from Operations Cash flow from operations for the second quarter of 2025 was $35 million, as compared to $15 million for the second quarter of 2024, an increase of $20 million. Cash flow from operations was positively impacted primarily by improvement in working capital, offset by financing fees related to the refinancing debt transaction. Earnings Per Share GAAP Earnings Per Share ('EPS') Basic and Diluted attributable to Bausch + Lomb Corporation for the second quarter of 2025 was ($0.18), as compared to ($0.43) for the second quarter of 2024. Adjusted EPS attributable to Bausch + Lomb Corporation (non-GAAP)1 for the second quarter of 2025 was $0.07, as compared to $0.13 for the second quarter of 2024. Adjusted EPS attributable to Bausch + Lomb Corporation excluding Acquired IPR&D (non-GAAP)1 for the second quarter of 2025 was $0.07, as compared to $0.14 for the second quarter of 2024. Adjusted EBITDA (non-GAAP)1; Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)1 Adjusted EBITDA (non-GAAP)1 was $191 million for the second quarter of 2025, as compared to $209 million for the second quarter of 2024, a decrease of $18 million. Adjusted EBITDA excluding Acquired IPR&D (non-GAAP)1 was $192 million for the second quarter of 2025, as compared to $212 million for the second quarter of 2024, a decrease of $20 million. The change was primarily due to the decrease in operating results, as noted above. 2025 Financial Outlook2 Bausch + Lomb provided updated guidance for the full year of 2025 as follows: As of April 30, 2025 As of July 30, 20253 Full-Year Revenue $5.000B – $5.100B ~4.5 – 6.5% constant currency growth1 $5.050B – $5.150B ~5 – 7% constant currency growth1 Full-Year Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)1 $850M – $900M $860M – $910M Full-Year Revenue Foreign Exchange Tailwinds Nominal $25M Full-Year Adj. EBITDA Excluding Acquired IPR&D (non-GAAP)1 Foreign Exchange Tailwinds Nominal Nominal Expand Other than with respect to GAAP revenue, the company only provides guidance on a non-GAAP basis. The company does not provide a reconciliation of forward-looking Adjusted EBITDA excluding Acquired IPR&D (non-GAAP)1 to GAAP net income (loss) attributable to Bausch + Lomb Corporation or of forward-looking constant currency revenue growth1 to reported revenue growth, due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliations. These amounts may be material and, therefore, could result in the projected GAAP measure or ratio being materially different or less than the projected non-GAAP measure or ratio. These statements represent forward-looking information and may represent a financial outlook, and actual results may vary. Please see the risks and assumptions referred to in the Forward-looking Statements section of this news release. Balance Sheet Highlights Bausch + Lomb's cash, cash equivalents and restricted cash were $272 million at June 30, 2025 Basic weighted average shares outstanding for the second quarter of 2025 were 353.7 million and diluted weighted average shares outstanding for the second quarter of 2025 were 355.5 million4 Conference Call Details Date: Wednesday, July 30, 2025 Time: 8:00 a.m. ET Webcast: Participant Event Dial-in: +1 (888) 506-0062 (North America) +1 (973) 528-0011 (International) Participant Access Code: 155159 Replay Dial-in: +1 (877) 481-4010 (North America) +1 (919) 882-2331 (International) Replay Passcode: 51714 (replay available until August 13, 2025) Expand About Bausch + Lomb Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit and connect with us on Facebook, Instagram, LinkedIn, X and YouTube. Forward-looking Statements This news release contains forward-looking information and statements within the meaning of applicable securities laws (collectively, 'forward-looking statements'), which may generally be identified by the use of the words 'anticipates,' 'hopes,' 'expects,' 'intends,' 'plans,' 'projects,' 'predicts,' 'forecasts,' 'should,' 'could,' 'would,' 'may,' 'might,' 'will,' 'strive,' 'believes,' 'estimates,' 'potential,' 'target,' 'guidance,' 'outlook,' or 'continue' and positive and negative variations or similar expressions and phrases or statements that certain actions, events or results may, could, should or will be achieved, received or taken, or will occur or result, and similar such expressions also identify forward-looking information. Forward-looking statements include statements regarding Bausch + Lomb's future prospects and performance, including the company's 2025 full-year guidance and the performance of certain products. These forward-looking statements, including the company's full-year guidance, are based upon the current expectations and beliefs of management and are provided for the purpose of providing additional information about such expectations and beliefs, and readers are cautioned that these statements may not be appropriate for other purposes. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb's filings with the U.S. Securities and Exchange Commission ('SEC') and the Canadian Securities Administrators (the 'CSA') (including the company's Annual Report on Form 10-K for the year ended Dec. 31, 2024 (which was filed with the SEC and CSA on Feb. 19, 2025) and its most recent quarterly filings), which factors are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties respecting the proposed plan to separate Bausch + Lomb into an independent, publicly traded company, separate from the remainder of Bausch Health Companies Inc. ('BHC') (the 'separation'), which include, but are not limited to, the expected benefits and costs of the separation, the expected timing of completion of the separation and its manner and terms (including that it may include the transfer of all or a portion of BHC's remaining direct or indirect equity interest in Bausch + Lomb to its shareholders (the 'distribution')), the expectation that, if the separation is to be effected through a distribution, then it will be completed following the achievement of targeted debt leverage ratios, subject to receipt of applicable shareholder and other necessary approvals and other factors, including those described in BHC's public statements, the ability to complete the distribution considering the various conditions to the completion of the distribution (some of which are outside the company's and BHC's control, including conditions related to regulatory matters and receipt of applicable shareholder and other approvals), the impact of any potential sales or dispositions of the company's common shares by BHC (including in connection with a foreclosure on the Bausch + Lomb common shares owned by BHC that are or may be pledged as collateral for certain of BHC's debt), that market or other conditions are no longer favorable to completing the transaction, that applicable shareholder, stock exchange, regulatory or other approval is not obtained on the terms or timelines anticipated or at all, business disruption during the pendency of or following the separation, diversion of management time on separation-related issues, retention of existing management team members, the reaction of customers and other parties to the separation, the structure of the distribution, the qualification of the distribution as a tax-free transaction for Canadian and/or U.S. federal income tax purposes (including whether or not an advance ruling from the Canada Revenue Agency and/or the Internal Revenue Service will be sought or obtained), the ability of the company and BHC to satisfy the conditions required to maintain the tax-free status of such distribution (some of which are beyond their control), other potential tax or other liabilities that may arise as a result of the distribution, the potential dis-synergy costs resulting from the separation, the impact of the separation on relationships with customers, suppliers, employees and other business counterparties, general economic conditions, conditions in the markets the company is engaged in, behavior of customers, suppliers and competitors, technological developments and legal and regulatory rules affecting the company's business. In particular, the company can offer no assurance that the separation will occur at all, or that any such transaction will occur on the terms and timelines or in the manner anticipated by the company and BHC. They also include risks and uncertainties relating to acquisitions and other business development transactions the company has completed or may, in the future, pursue and complete, such as the acquisition of XIIDRA® and certain other ophthalmology assets and the acquisition of Elios Vision, Inc., TearLab Corporation, d/b/a Trukera Medical and Whitecap Biosciences, LLC, including risks that the company may not realize the expected benefits of those transactions on a timely basis or at all and, where applicable, risks relating to increased levels of debt as a result of debt incurred to finance such transactions, including in regards to compliance with our debt covenants. They also include risks relating to the voluntary recall of certain of our enVista® IOL products, including our ability to resupply inventory to the market and the success of the enhanced protocols we have put in place (including the enhanced inspection protocols for IOLs and more explicit standards for third party suppliers). They also include the expected impact of the tariffs imposed by the U.S. and counter-tariffs or other retaliatory measures imposed on the U.S. by other countries and disruptions to global supply chains and other potential results as a result of these developments and our ability to successfully manage the expected impact of such tariffs and counter-tariffs and other measures, including the success of our planned actions and levers to manage these matters. Finally, they also include, but are not limited to, risks and uncertainties caused by or relating to adverse economic conditions and other macroeconomic factors, including heightened inflation and interest rates, fluctuations in exchange rates, imposition of and adverse changes to tariff, duties and other trade protection measures, slower growth or a potential recession, which could adversely impact our revenue, expenses and resulting margins. In addition, certain material factors and assumptions have been applied in making these forward-looking statements, including, without limitation, the assumption that the risks and uncertainties outlined above will not cause actual results or events to differ materially from those described in these forward-looking statements. In addition, management has also made certain assumptions regarding our 2025 full-year guidance with respect to expectations regarding base performance growth, business performance, currency impact, impacts of inflation, the company's ability to offset the impact of tariffs in 2025 (based on the current tariff policy and the actions the company is taking to manage these measures), adjusted gross margin (non-GAAP), adjusted SG&A expense (non-GAAP) and the company's ability to continue to manage such expense in the manner anticipated, interest expense (which will vary based on, among other things, interest rates and our indebtedness), adjusted tax rate and full-year capex and the anticipated timing and extent of the company's R&D expense. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch + Lomb undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. Links provided in this news release are solely for information purposes and do not constitute Bausch + Lomb affirming any forward-looking statements contained in the linked content. Non-GAAP Information To supplement the financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), the company uses certain non-GAAP financial measures and ratios. Management uses these non-GAAP measures and ratios as key metrics in the evaluation of the company's performance and the consolidated financial results and, in part, in the determination of cash bonuses for its executive officers. The company believes these non-GAAP measures and ratios are useful to investors in their assessment of our operating performance and the valuation of the company. In addition, these non-GAAP measures and ratios address questions the company routinely receives from analysts and investors, and in order to assure that all investors have access to similar data, the company has determined that it is appropriate to make this data available to all investors. These measures and ratios do not have any standardized meaning under GAAP and other companies may use similarly titled non-GAAP financial measures and ratios that are calculated differently from the way we calculate such measures and ratios. Accordingly, our non-GAAP financial measures and ratios may not be comparable to similar non-GAAP measures and ratios of other companies. We caution investors not to place undue reliance on such non-GAAP measures and ratios, but instead to consider them with the most directly comparable GAAP measures and ratios. Non-GAAP financial measures and ratios have limitations as analytical tools and should not be considered in isolation. They should be considered as a supplement to, not a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. The reconciliations of these historic non-GAAP financial measures and ratios to the most directly comparable financial measures and ratios calculated and presented in accordance with GAAP are shown in the tables below. Specific Non-GAAP Measures EBITDA, Adjusted EBITDA and Adjusted EBITDA excluding Acquired IPR&D EBITDA (non-GAAP) is Net income (loss) attributable to Bausch + Lomb Corporation (its most directly comparable U.S. GAAP financial measure) adjusted for interest, income taxes, depreciation and amortization. Adjusted EBITDA (non-GAAP) is EBITDA (non-GAAP) further adjusted for the items described below. Management believes that Adjusted EBITDA (non-GAAP), along with the GAAP measures used by management, most appropriately reflect how the company measures the business internally and sets operational goals and incentives. In particular, the company believes that Adjusted EBITDA (non-GAAP) focuses management on the company's underlying operational results and business performance. As a result, the company uses Adjusted EBITDA (non-GAAP) both to assess the actual financial performance of the company and to forecast future results as part of its guidance. Management believes Adjusted EBITDA (non-GAAP) is a useful measure to evaluate current performance. Adjusted EBITDA (non-GAAP) is intended to show our unleveraged, pre-tax operating results and therefore reflects our financial performance based on operational factors. In addition, cash bonuses for the company's executive officers and other key employees are based, in part, on the achievement of certain Adjusted EBITDA (non-GAAP) targets. Adjusted EBITDA (non-GAAP) is Net income (loss) attributable to Bausch + Lomb Corporation (its most directly comparable U.S. GAAP financial measure) adjusted for interest expense, net, (benefit from) provision for income taxes, depreciation and amortization and further adjusted for the following items: Asset impairments : The company has excluded the impact of impairments of finite-lived and indefinite-lived intangible assets as such amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions and divestitures. The company believes that the adjustments of these items correlate with the sustainability of the company's operating performance. Although the company excludes impairments of intangible assets from measuring the performance of the company and its business, the company believes that it is important for investors to understand that intangible assets contribute to revenue generation. : The company has excluded the impact of impairments of finite-lived and indefinite-lived intangible assets as such amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions and divestitures. The company believes that the adjustments of these items correlate with the sustainability of the company's operating performance. Although the company excludes impairments of intangible assets from measuring the performance of the company and its business, the company believes that it is important for investors to understand that intangible assets contribute to revenue generation. Restructuring, integration and transformation costs: The company has incurred restructuring costs as it implemented certain strategies, which involved, among other things, improvements to its infrastructure and operations, internal reorganizations and impacts from the divestiture of assets and businesses. With regard to infrastructure and operational improvements which the company has taken to improve efficiencies in the businesses and facilities, these tend to be costs intended to right size the business or organization that fluctuate significantly between periods in amount, size and timing, depending on the improvement project, reorganization or transaction. Additionally, with the completion of the Bausch + Lomb IPO, as the company prepares for post-separation operations, the company is launching certain transformation initiatives that will result in certain changes to and investment in its organizational structure and operations. These transformation initiatives arise outside of the ordinary course of continuing operations and, as is the case with the company's restructuring efforts, costs associated with these transformation initiatives are expected to fluctuate between periods in amount, size and timing. These out-of-the-ordinary-course charges include third-party advisory costs, as well as certain compensation-related costs. Investors should understand that the outcome of these transformation initiatives may result in future restructuring actions and certain of these charges could recur. The company believes that the adjustments of these items provide supplemental information with regard to the sustainability of the company's operating performance, allow for a comparison of the financial results to historical operations and forward-looking guidance and, as a result, provide useful supplemental information to investors. The company has incurred restructuring costs as it implemented certain strategies, which involved, among other things, improvements to its infrastructure and operations, internal reorganizations and impacts from the divestiture of assets and businesses. With regard to infrastructure and operational improvements which the company has taken to improve efficiencies in the businesses and facilities, these tend to be costs intended to right size the business or organization that fluctuate significantly between periods in amount, size and timing, depending on the improvement project, reorganization or transaction. Additionally, with the completion of the Bausch + Lomb IPO, as the company prepares for post-separation operations, the company is launching certain transformation initiatives that will result in certain changes to and investment in its organizational structure and operations. These transformation initiatives arise outside of the ordinary course of continuing operations and, as is the case with the company's restructuring efforts, costs associated with these transformation initiatives are expected to fluctuate between periods in amount, size and timing. These out-of-the-ordinary-course charges include third-party advisory costs, as well as certain compensation-related costs. Investors should understand that the outcome of these transformation initiatives may result in future restructuring actions and certain of these charges could recur. The company believes that the adjustments of these items provide supplemental information with regard to the sustainability of the company's operating performance, allow for a comparison of the financial results to historical operations and forward-looking guidance and, as a result, provide useful supplemental information to investors. Acquisition-related costs and adjustments excluding amortization of intangible assets : The company has excluded the impact of acquisition-related costs and fair value inventory step-up resulting from acquisitions as the amounts and frequency of such costs and adjustments are not consistent and are significantly impacted by the timing and size of its acquisitions. In addition, the company excludes the impact of acquisition-related contingent consideration non-cash adjustments due to the inherent uncertainty and volatility associated with such amounts based on changes in assumptions with respect to fair value estimates, and the amount and frequency of such adjustments are not consistent and are significantly impacted by the timing and size of the company's acquisitions, as well as the nature of the agreed-upon consideration. : The company has excluded the impact of acquisition-related costs and fair value inventory step-up resulting from acquisitions as the amounts and frequency of such costs and adjustments are not consistent and are significantly impacted by the timing and size of its acquisitions. In addition, the company excludes the impact of acquisition-related contingent consideration non-cash adjustments due to the inherent uncertainty and volatility associated with such amounts based on changes in assumptions with respect to fair value estimates, and the amount and frequency of such adjustments are not consistent and are significantly impacted by the timing and size of the company's acquisitions, as well as the nature of the agreed-upon consideration. Share-based compensation : The company excludes costs relating to share-based compensation. The company believes that the exclusion of share-based compensation expense assists investors in the comparisons of operating results to peer companies. Share-based compensation expense can vary significantly based on the timing, size and nature of awards granted. : The company excludes costs relating to share-based compensation. The company believes that the exclusion of share-based compensation expense assists investors in the comparisons of operating results to peer companies. Share-based compensation expense can vary significantly based on the timing, size and nature of awards granted. Separation costs and separation-related costs : The company has excluded certain costs incurred in connection with activities taken to: (i) separate the Bausch + Lomb business from the remainder of BHC and (ii) register the Bausch + Lomb business as an independent publicly traded entity. Separation costs are incremental costs directly related to effectuating the separation of the Bausch + Lomb business from the remainder of BHC and include, but are not limited to, legal, audit and advisory fees, talent acquisition costs and costs associated with establishing a new Board of Directors and Audit Committee. Separation-related costs are incremental costs indirectly related to the separation of the Bausch + Lomb business from the remainder of BHC and include, but are not limited to, IT infrastructure and software licensing costs, rebranding costs and costs associated with facility relocation and/or modification. As these costs arise from events outside of the ordinary course of continuing operations, the company believes that the adjustments of these items provide supplemental information with regard to the sustainability of the company's operating performance, allow for a comparison of the financial results to historical operations and forward-looking guidance and, as a result, provide useful supplemental information to investors. : The company has excluded certain costs incurred in connection with activities taken to: (i) separate the Bausch + Lomb business from the remainder of BHC and (ii) register the Bausch + Lomb business as an independent publicly traded entity. Separation costs are incremental costs directly related to effectuating the separation of the Bausch + Lomb business from the remainder of BHC and include, but are not limited to, legal, audit and advisory fees, talent acquisition costs and costs associated with establishing a new Board of Directors and Audit Committee. Separation-related costs are incremental costs indirectly related to the separation of the Bausch + Lomb business from the remainder of BHC and include, but are not limited to, IT infrastructure and software licensing costs, rebranding costs and costs associated with facility relocation and/or modification. As these costs arise from events outside of the ordinary course of continuing operations, the company believes that the adjustments of these items provide supplemental information with regard to the sustainability of the company's operating performance, allow for a comparison of the financial results to historical operations and forward-looking guidance and, as a result, provide useful supplemental information to investors. Other Non-GAAP adjustments : The company also excludes certain other amounts, including IT infrastructure investment, litigation and other matters, gain/(loss) on sales of assets and certain other amounts that are the result of other, non-comparable events to measure operating performance if and when present in the periods presented. These events arise outside of the ordinary course of continuing operations. Given the unique nature of the matters relating to these costs, the company believes these items are not routine operating expenses. For example, legal settlements and judgments vary significantly, in their nature, size and frequency, and, due to this volatility, the company believes the costs associated with legal settlements and judgments are not routine operating expenses. The company excluded these costs as this event is outside of the ordinary course of continuing operations and infrequent in nature. The company believes that the exclusion of such out-of-the-ordinary-course amounts provides supplemental information to assist in the comparison of the financial results of the company from period to period and, therefore, provides useful supplemental information to investors. However, investors should understand that many of these costs could recur and that companies in our industry often face litigation. Adjusted EBITDA excluding Acquired In-Process Research and Development (IPR&D) (non-GAAP) is Adjusted EBITDA (non-GAAP) further adjusted to exclude Acquired IPR&D. The IPR&D expenditures represent costs directly resulting from business development transactions and not through the normal course of business. The company believes that the exclusion of such out-of-the-ordinary-course amounts provides supplemental information to assist in the comparison of the financial results of the company from period to period and, therefore, provides useful supplemental information to investors in assessing our performance. However, investors should understand that the company may enter into additional business development transactions in the future and, as a result, such Acquired IPR&D may recur in the future. Adjusted Net Income (non-GAAP) Adjusted net income (non-GAAP) is net income (loss) attributable to Bausch + Lomb Corporation (its most directly comparable GAAP financial measure) adjusted for asset impairments, restructuring, integration and transformation costs, acquisition-related contingent consideration, separation costs and separation-related costs and other non-GAAP adjustments, as these adjustments are described above, and further adjusted for amortization of intangible assets and loss on extinguishment of debt and write-down of financing fees, as described below: Amortization of intangible assets : The company has excluded the impact of amortization of intangible assets, as such amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. The company believes that the adjustments of these items correlate with the sustainability of the company's operating performance. Although the company excludes the amortization of intangible assets from its non-GAAP expenses, the company believes that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in the amortization of additional intangible assets. : The company has excluded the impact of amortization of intangible assets, as such amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. The company believes that the adjustments of these items correlate with the sustainability of the company's operating performance. Although the company excludes the amortization of intangible assets from its non-GAAP expenses, the company believes that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in the amortization of additional intangible assets. Loss on extinguishment of debt and write-down of financing fees : The company has excluded loss on extinguishment of debt and write-down of financing fees as this represents a loss from refinancing our existing debt and is not a reflection of our operations for the period. Further, the amount and frequency of such amounts are not consistent and are significantly impacted by the timing and size of debt financing transactions and other factors in the debt market that are not in management's control. Bausch + Lomb did not have any material losses on extinguishment of debt and write-downs of financing fees prior to the second quarter of 2025. Adjusted net income (non-GAAP) excludes the impact of these certain items that may obscure trends in the company's underlying performance. Management uses Adjusted net income (non-GAAP) for strategic decision making, forecasting future results and evaluating current performance. By disclosing this non-GAAP measure, it is management's intention to provide investors with a meaningful, supplemental comparison of the company's operating results and trends for the periods presented. Management believes that this measure is also useful to investors as such measure allows investors to evaluate the company's performance using the same tools that management uses to evaluate past performance and prospects for future performance. Accordingly, the company believes that Adjusted net income (non-GAAP) is useful to investors in their assessment of the company's operating performance and the valuation of the company. It is also noted that, in recent periods, our GAAP net income (loss) attributable to Bausch + Lomb Corporation was significantly lower than our Adjusted net income (non-GAAP). Constant Currency Constant currency change or constant currency revenue growth is a change in GAAP revenue (its most directly comparable GAAP financial measure) on a period-over-period basis adjusted for changes in foreign currency exchange rates. The company uses Constant Currency revenue (non-GAAP) and Constant Currency revenue Growth (non-GAAP) to assess performance of its reportable segments, and the company in total, without the impact of foreign currency exchange fluctuations. The company believes that such measures are useful to investors as they provide a supplemental period-to-period comparison. Although changes in foreign currency exchange rates are part of our business, they are not within management's control. Changes in foreign currency exchange rates, however, can mask positive or negative trends in the underlying business performance. Constant currency impact is determined by comparing 2025 reported amounts adjusted to exclude currency impact, calculated using 2024 monthly average exchange rates, to the actual 2024 reported amounts. Adjusted EPS (non-GAAP) and Adjusted EPS excluding Acquired IPR&D (non-GAAP) Adjusted earnings per share or Adjusted EPS (non-GAAP) is calculated as Diluted income per share attributable to Bausch + Lomb Corporation ('GAAP EPS') (its most directly comparable GAAP financial measure), adjusted for the per diluted share impact of each adjustment made to reconcile Net income (loss) attributable to Bausch + Lomb Corporation to Adjusted net income (non-GAAP) as discussed above. Adjusted EPS excluding Acquired IPR&D (non-GAAP) is Adjusted EPS (non-GAAP) further adjusted for the per diluted share impact of Acquired IPR&D. Like Adjusted net income (non-GAAP), Adjusted EPS (non-GAAP) and Adjusted EPS excluding Acquired IPR&D (non-GAAP) excludes the impact of certain items that may obscure trends in the company's underlying performance on a per share basis. By disclosing these non-GAAP measures, it is management's intention to provide investors with a meaningful, supplemental comparison of the company's results and trends for the periods presented on a diluted share basis. Accordingly, the company believes that Adjusted EPS (non-GAAP) and Adjusted EPS excluding Acquired IPR&D (non-GAAP) are useful to investors in their assessment of the company's operating performance, the valuation of the company and an investor's return on investment. It is also noted that, for the periods presented, our GAAP EPS was significantly lower than our Adjusted EPS (non-GAAP) and Adjusted EPS excluding Acquired IPR&D (non-GAAP). © 2025 Bausch + Lomb. _____________________________________ 1 This is a non-GAAP measure or a non-GAAP ratio. For further information on non-GAAP measures and non-GAAP ratios, please refer to the 'Non-GAAP Information' section of this news release. Please also refer to tables at the end of this news release for a reconciliation of this and other non-GAAP measures to the most directly comparable GAAP measure. 2 The guidance in this news release is only effective as of the date given, July 30, 2025, and will not be updated or affirmed unless and until the company publicly announces updated or affirmed guidance. Distribution or reference of this news release following July 30, 2025, does not constitute the company reaffirming guidance. See the 'Forward-looking Statements' section for further information. 3 The increase in the anticipated full-year revenue is a result of strong business performance and an increase in expected currency tailwinds (a result of the weakening of the U.S. dollar relative to other currencies). The increases in anticipated constant currency revenue growth and anticipated Adjusted EBITDA excluding Acquired IPR&D are a result of strong business performance. 4 Diluted weighted average shares includes the dilutive impact of options, performance based restricted stock units and restricted stock units, which are approximately 1,800,000 common shares for the 3 months ended June 30, 2025, and which are excluded when calculating GAAP diluted loss per share because the effect of including the impact would be anti-dilutive. Expand FINANCIAL TABLES FOLLOW Bausch + Lomb Corporation Table 1 Consolidated Statements of Operations For the Three and Six Months Ended June 30, 2025 and 2024 (unaudited) Three Months Ended Six Months Ended June 30, June 30, (in millions, except per share amounts) 2025 2024 2025 2024 Revenues Product sales $ 1,272 $ 1,213 $ 2,405 $ 2,307 Other revenues 6 3 10 8 1,278 1,216 2,415 2,315 Expenses Cost of goods sold (excluding amortization and impairments of intangible assets) 523 482 1,004 905 Cost of other revenues 2 1 3 2 Selling, general and administrative 579 535 1,142 1,039 Research and development 96 84 182 166 Amortization of intangible assets 67 74 134 148 Other expense, net 22 14 44 23 1,289 1,190 2,509 2,283 Operating (loss) income (11 ) 26 (94 ) 32 Interest income 3 3 6 6 Interest expense (128 ) (102 ) (222 ) (201 ) Loss on extinguishment of debt (9 ) — (9 ) — Foreign exchange and other (2 ) (3 ) (8 ) (3 ) Loss before provision for income taxes (147 ) (76 ) (327 ) (166 ) Benefit from (provision for income taxes) 89 (72 ) 58 (145 ) Net loss (58 ) (148 ) (269 ) (311 ) Net income attributable to noncontrolling interest (4 ) (3 ) (5 ) (7 ) Net loss attributable to Bausch + Lomb Corporation $ (62 ) $ (151 ) $ (274 ) $ (318 ) Basic and diluted loss per share attributable to Bausch + Lomb Corporation $ (0.18 ) $ (0.43 ) $ (0.78 ) $ (0.90 ) Basic weighted-average common shares 353.7 351.8 353.3 351.5 Diluted weighted-average common shares 353.7 351.8 353.3 351.5 Expand Bausch + Lomb Corporation Table 2 Reconciliation of GAAP Net Loss and Diluted Loss per Share Attributable to Bausch + Lomb Corporation to Adjusted Net Income (Loss) (non-GAAP) and Adjusted Earnings (Loss) Per Share (non-GAAP) For the Three and Six Months Ended June 30, 2025 and 2024 (unaudited) Three Months Ended June 30, 2025 2024 (in millions, except per share amounts) Income (Expense) Earnings per Share Impact Income (Expense) Earnings per Share Impact Net loss and Diluted loss per share attributable to Bausch + Lomb Corporation $ (62 ) $ (0.18 ) $ (151 ) $ (0.43 ) Non-GAAP adjustments: (a) Amortization of intangible assets 67 0.19 74 0.21 Asset impairments — — 5 0.01 Restructuring, integration and transformation costs 53 0.15 27 0.08 Acquisition-related costs and adjustments (excluding amortization of intangible assets) 5 0.01 21 0.06 Loss on extinguishment of debt and write-down of financing fees 40 0.11 — — Separation costs and separation-related costs — — 1 — Gain on sale of assets — — (1 ) — Other 13 0.04 4 0.01 Tax effect of non-GAAP adjustments (91 ) (0.25 ) 65 0.19 Total non-GAAP adjustments 87 0.25 196 0.56 Adjusted net income (non-GAAP) and Adjusted earnings per share (non-GAAP) $ 25 $ 0.07 $ 45 $ 0.13 Acquired IPR&D 1 — 3 0.01 Adjusted net income excluding Acquired IPR&D (non-GAAP) and Adjusted earnings per share excluding Acquired IPR&D (non-GAAP) $ 26 $ 0.07 $ 48 $ 0.14 Expand Six Months Ended June 30, 2025 2024 (in millions, except per share amounts) Income (Expense) Earnings per Share Impact Income (Expense) Earnings per Share Impact Net loss and Diluted loss per share attributable to Bausch + Lomb Corporation $ (274 ) $ (0.78 ) $ (318 ) $ (0.90 ) Non-GAAP adjustments: (a) Amortization of intangible assets 134 0.38 148 0.42 Asset impairments — — 5 0.01 Restructuring, integration and transformation costs 91 0.26 55 0.15 Acquisition-related costs and adjustments (excluding amortization of intangible assets) 19 0.05 42 0.12 Loss on extinguishment of debt and write-down of financing fees 40 0.11 — — Separation costs and separation-related costs — — 3 0.01 Gain on sale of assets — — (5 ) (0.01 ) Other 15 0.04 6 0.02 Tax effect of non-GAAP adjustments (54 ) (0.14 ) 133 0.38 Total non-GAAP adjustments 245 0.70 387 1.10 Adjusted net (loss) income (non-GAAP) and Adjusted (loss) earnings per share (non-GAAP) $ (29 ) $ (0.08 ) $ 69 $ 0.20 Acquired IPR&D 29 0.08 3 0.01 Adjusted net income excluding Acquired IPR&D (non-GAAP) and Adjusted earnings per share excluding Acquired IPR&D (non-GAAP) $ — $ — $ 72 $ 0.21 Expand (a) The components of and further details respecting each of these non-GAAP adjustments and the financial statement line item to which each component relates can be found on Table 2a. Expand Bausch + Lomb Corporation Table 2a Reconciliation of GAAP to Non-GAAP Financial Information For the Three and Six Months Ended June 30, 2025 and 2024 (unaudited) Three Months Ended Six Months Ended June 30, June 30, (in millions) 2025 2024 2025 2024 Cost of goods sold reconciliation: GAAP Cost of goods sold (excluding amortization and impairments of intangible assets) $ 523 $ 482 $ 1,004 $ 905 Fair value inventory step-up resulting from acquisitions (a) (21 ) (20 ) (43 ) (40 ) Adjusted cost of goods sold (excluding amortization and impairments of intangible assets) (non-GAAP) $ 502 $ 462 $ 961 $ 865 Selling, general and administrative reconciliation: GAAP Selling, general and administrative $ 579 $ 535 $ 1,142 $ 1,039 Separation-related costs (b) — (1 ) (1 ) (2 ) Transformation costs (c) (22 ) (21 ) (58 ) (38 ) Other (d) (6 ) (2 ) (6 ) (3 ) Adjusted selling, general and administrative (non-GAAP) $ 551 $ 511 $ 1,077 $ 996 Research and development reconciliation: GAAP Research and development $ 96 $ 84 $ 182 $ 166 Separation-related costs (b) — — — (1 ) Adjusted research and development (non-GAAP) $ 96 $ 84 $ 182 $ 165 Amortization of intangible assets reconciliation: GAAP Amortization of intangible assets $ 67 $ 74 $ 134 $ 148 Amortization of intangible assets (e) (67 ) (74 ) (134 ) (148 ) Adjusted amortization of intangible assets (non-GAAP) $ — $ — $ — $ — Other expense, net reconciliation: GAAP Other expense, net $ 22 $ 14 $ 44 $ 23 Litigation and other matters (d) (6 ) — (7 ) (1 ) Restructuring and integration costs (c) (31 ) (6 ) (33 ) (17 ) Asset impairments (f) — (5 ) — (5 ) Separation costs (b) — — 1 — Acquisition-related contingent consideration (a) 18 — 27 (1 ) Acquisition-related costs (a) (2 ) (1 ) (3 ) (1 ) Gain on sale of assets (g) — 1 — 5 Adjusted other expense, net (non-GAAP) $ 1 $ 3 $ 29 $ 3 Interest expense reconciliation: GAAP Interest expense $ (128 ) $ (102 ) $ (222 ) $ (201 ) Write-down of financing fees (h) 31 — 31 — Adjusted interest expense (non-GAAP) $ (97 ) $ (102 ) $ (191 ) $ (201 ) Loss on extinguishment of debt reconciliation: GAAP Loss on extinguishment of debt $ (9 ) $ — $ (9 ) $ — Loss on extinguishment of debt (h) 9 — 9 — Adjusted loss on extinguishment of debt (non-GAAP) $ — $ — $ — $ — Foreign exchange and other reconciliation: GAAP Foreign exchange and other $ (2 ) $ (3 ) $ (8 ) $ (3 ) Other (d) 1 2 2 2 Adjusted foreign exchange and other (non-GAAP) $ (1 ) $ (1 ) $ (6 ) $ (1 ) Benefit from (provision for) income taxes reconciliation: GAAP Benefit from (provision for) income taxes $ 89 $ (72 ) $ 58 $ (145 ) Tax effect of non-GAAP adjustments (i) (91 ) 65 (54 ) 133 Adjusted (provision for) benefit from income taxes (non-GAAP) $ (2 ) $ (7 ) $ 4 $ (12 ) Expand (a) Represents the three components of the non-GAAP adjustment of 'Acquisition-related costs and adjustments (excluding amortization of intangible assets)' (see Table 2). (b) Represents the three components of the non-GAAP adjustment of 'Separation costs and separation-related costs' (see Table 2). (c) Represents the two components of the non-GAAP adjustment of 'Restructuring, integration and transformation costs' (see Table 2). (d) Represents the three components of the non-GAAP adjustment of 'Other' (see Table 2). (e) Represents the sole component of the non-GAAP adjustment of 'Amortization of intangible assets' (see Table 2). (f) Represents the sole component of the non-GAAP adjustment of 'Asset impairments' (see Table 2). (g) Represents the sole component of the non-GAAP adjustment of 'Gain on sale of assets' (see Table 2). (h) Represents the two components of the non-GAAP adjustment of 'Loss on extinguishment of debt and write-down of financing fees' (see Table 2). (i) Represents the sole component of the non-GAAP adjustment of 'Tax effect of non-GAAP adjustments' (see Table 2). Expand Bausch + Lomb Corporation Table 2b Reconciliation of GAAP Net Loss to Adjusted EBITDA (non-GAAP) For the Three and Six Months Ended June 30, 2025 and 2024 (unaudited) Three Months Ended Six Months Ended June 30, June 30, (in millions) 2025 2024 2025 2024 Net loss attributable to Bausch + Lomb Corporation $ (62 ) $ (151 ) $ (274 ) $ (318 ) Interest expense, net 125 99 216 195 (Benefit from) provision for income taxes (89 ) 72 (58 ) 145 Depreciation and amortization of intangible assets 107 110 213 220 EBITDA 81 130 97 242 Adjustments: Asset impairments — 5 — 5 Restructuring, integration and transformation costs 53 27 91 55 Acquisition-related costs and adjustments (excluding amortization of intangible assets) 5 21 19 42 Share-based compensation 30 22 58 41 Separation costs and separation-related costs — 1 — 3 Loss on extinguishment of debt 9 — 9 — Other non-GAAP adjustments: Gain on sale of assets — (1 ) — (5 ) Other 13 4 15 6 Adjusted EBITDA (non-GAAP) $ 191 $ 209 $ 289 $ 389 Acquired IPR&D 1 3 29 3 Adjusted EBITDA excluding Acquired IPR&D (non-GAAP) $ 192 $ 212 $ 318 $ 392 Expand Bausch + Lomb Corporation Table 3 Constant Currency Revenue (non-GAAP) and Constant Currency Revenue Growth (non-GAAP) - by Segment For the Three and Six Months Ended June 30, 2025 and 2024 (unaudited) Calculation of Constant Currency Revenue for the Three Months Ended June 30, 2025 June 30, 2024 Change in Revenue as Reported Change in Constant Currency Revenue (Non-GAAP) (b) Revenue as Reported Changes in Exchange Rates (a) Constant Currency Revenue (Non-GAAP) (b) Revenue as Reported (in millions) Amount Pct. Amount Pct. Vision Care $ 753 $ (14 ) $ 739 $ 697 $ 56 8 % $ 42 6 % Surgical 216 (5 ) 211 209 7 3 % 2 1 % Pharmaceuticals 309 (2 ) 307 310 (1 ) — % (3 ) (1 )% Total revenues $ 1,278 $ (21 ) $ 1,257 $ 1,216 $ 62 5 % $ 41 3 % Calculation of Constant Currency Revenue for the Six Months Ended June 30, 2025 June 30, 2024 Change in Revenue as Reported Change in Constant Currency Revenue (Non-GAAP) (b) Revenue as Reported Changes in Exchange Rates (a) Constant Currency Revenue (Non-GAAP) (b) Revenue as Reported (in millions) Amount Pct. Amount Pct. Vision Care $ 1,409 $ (1 ) $ 1,408 $ 1,332 $ 77 6 % $ 76 6 % Surgical 430 (1 ) 429 406 24 6 % 23 6 % Pharmaceuticals 576 — 576 577 (1 ) — % (1 ) — % Total revenues $ 2,415 $ (2 ) $ 2,413 $ 2,315 $ 100 4 % $ 98 4 % Expand (a) The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported revenues revalued using the monthly average currency exchange rates during the comparable prior period. (b) To supplement the financial measures prepared in accordance with GAAP, the Company uses certain non-GAAP financial measures and ratios. For additional information about the Company's use of such non-GAAP financial measures and ratios, refer to the 'Non-GAAP Information' section in the body of the news release to which these tables are attached. Constant currency revenue (non-GAAP) for the three and six months ended June 30, 2025 is calculated as revenue as reported adjusted for the impact for changes in exchange rates (previously defined in this news release). Change in constant currency revenue (non-GAAP) is calculated as the difference between constant currency revenue for the current period and revenue as reported for the comparative period. Expand
Newsweek
a day ago
- Entertainment
- Newsweek
Couple Check Pet Cam, Realize Cat Is Trying To Warn Them About Something
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. One-year-old Marble the cat has been praised online after he warned his owners that their fire was burning out of control while they were out of the house. On a winter evening last year, Sabeen Shaikh, 31, from San Francisco, hosted friends and lit the fireplace for Marble, who relishes the cozy warmth of crackling flames. When the evening wrapped up, the fire was extinguished and the group left for dessert. But soon after, Shaikh received a motion alert from her Blink pet camera—and the thumbnail was ablaze with bright orange. "We saw Marble standing in front of the camera with the blazing fireplace behind him," Shaikh told Newsweek. "We turned around and raced back home." Luckily, the couple were just two minutes away, and when they returned they realized the fire was contained in the hearth—not nearly as dramatic as the camera made it look. Marble the cat, sitting in front of the house camera as a warning, left, and a picture of the family rushing back to the house, right. Marble the cat, sitting in front of the house camera as a warning, left, and a picture of the family rushing back to the house, right. @sabeenshaikh94/TikTok Shaikh doused the embers with baking soda, and both Marble and his feline sibling Cheeto were completely unharmed. The moment was captured on the family's security cameras, and has since been shared on TikTok where it has been viewed more than 7 million times. In the comments, TikTokers shared their reactions to the heroic cat's actions. "She's looking at the camera like 'where y'all at?'" said Etherealkae. While viewer Lima wrote: "Thank god you had a camera in the right place, and a smart cat!" Another viewer, @ joked: "Plot twist—Marble was the one that reignited the fire." The full picture of Marble sitting in front of the blazing fireplace. The full picture of Marble sitting in front of the blazing fireplace. @sabeenshaikh94/TikTok "It was just a funny experience seeing marble standing in front of the camera so calmly with the blazing fire in the back," Shaikh said. "I'm overwhelmed with the views, likes, and comments. They are hilarious and I knew one day marble would the one who would make my TikTok go viral because he's such a silly boy!" This isn't the first time a pet has been dubbed a "hero" for warning their owners about a fire. In 2022, 9-month-old Rae from Oregon started barking at the door unexpectedly. When her owners looked out, they realized what was happening—a large wildfire was burning just outside the home. Because of Rae's helpful pre-warning, the family were able to put the fire out quickly and there was minimal damage to the home. Another dog was praised after he started scratching at the door in the early hours of Christmas eve. When the owners opened the door to see what was wrong, they realized why the pup was raising the alarm—the house was on fire. Thanks to the pup, the family were warned before the fire alarms even went off and were able to wake their children and get out of the burning building in time.
7NEWS
2 days ago
- Business
- 7NEWS
Best budget security camera: Why this ‘perfect' buy is a smart choice for Aussie homes
When it comes to home security cameras, names like Ring are the ones people repeat time and again. But a new — and more affordable — brand is currently making waves on Amazon Australia, thanks to its battery-powered and Alexa-integrated security camera that captures sharp daytime video wherever you are. Introducing Blink, sold on Amazon Australia, and its new Blink Outdoor 4. Described as a ' wireless smart security camera with up to two years of battery life that helps protect what matters most, from the Blink app on your smartphone', shoppers are already raving about the $149 buy and how good it is. The camera not only lets you see and speak to the people via the Blink app, but it also has infrared night vision so you can keep an eye on your home at night when you're not there too. One of the main things that sets the Blink camera apart from others on the market is its impressive two-year battery life. Others who love the idea of a smart home will be into the fact that it seamlessly integrates with Alexa. Simply connect to an Alexa-enabled device to engage live view, arm and disarm your system, and more using your voice. Some of Blink's best features are hidden behind a subscription, which you can access in Australia for around $4.95 per month for one device or $15 per month for an unlimited number of Blink cameras. But for basic home security, the camera will work by itself. You can also buy two Blink Outdoor Cameras for $279, three for $399, while f ive cameras are currently marked down to $249 from $599. Over on Amazon Australia, there is a raft of five-star reviews for Blink. ' This system is so good! The hardest part about the setup for me was remembering my WiFi password!!!' one shopper wrote. 'I am spewing that I bought the add on module because it comes with one... I literally thought given the price I'd have to buy all the extras but NO. This kit gives you absolutely everything you need to set up home monitoring.' Another added: 'I have been on the hunt for the perfect security camera for MONTHS now. Then this product came recommended to me by a friend. 'I wanted one that was wireless, had night vision, could be used outdoors, good quality picture, had an external storage option not just subscription only, and had two way talk through. This met all my requirements at an affordable price!' A third described the camera simply as ' small and convenient '.
CNET
7 days ago
- CNET
11 Tricks and Technologies to Keep Your Home Safe From Intruders
From summer vacations to evenings of play, you'll want to make sure your home is safe when you're away. And that certainly includes your yard and front porch, where CNET surveys have found that 1 in 6 adults have been victims of porch theft. But the right home security has a say about that, too. The right smart devices, tips and home practices can keep all intruders at bay and stop break-ins before they happen -- prevention, after all, is the best strategy. Here's what I suggest to stay one step ahead with your home security and keep trespassers from causing any harm. 1. Set motion detection lights to stun Floodlights can watch over backyards, driveways and similar spots. Blink Look for a security camera that's equipped with a spotlight or floodlights. You can set these lights to trigger via motion detection, and thanks to recent advantages, camera sensors are now smart enough to ignore cars and focus on people, among other useful tricks. The lights will let determined trespassers know that there's a security system, and even indicate that a camera is currently recording them. That's a powerful reason to get away if intruders have ill intent! Remember, apps from popular smart home brands like Arlo, Ring, Blink and many others allow you to set zones and control motion sensitivity so your security lights only turn on when a person gets close, instead of lighting up a dozen times a night. Read more: I Thought I'd Hate AI in Home Security. I Couldn't Have Been More Wrong 2. Put up a security system yard sign Security yard signs discourage many thieves. Kangaroo You may have already suspected it, but studies do confirm that burglars -- around 83% surveyed -- are scared off by signs that an alarm system is present, and one of the most straightforward is a literal sign or window sticker. We suggest avoiding cheap, fake signs, which are usually easy to recognize by someone already thinking about a break-in. Fortunately, real signs come included even with common DIY security systems like those offered by SimpliSafe. And if you're worried about a burglar using a sign to learn too much about your home security system, these sorts of hacking tales hardly ever actually happen. 3. Install a video doorbell for front door protection Kasa's very affordable doorbell can keep an eye on all kinds of front door events. Kasa It's hard to miss a video doorbell when approaching a front door or porch. From Google Nest to Arlo, Ring and Aqara, these doorbell cameras make it obvious that someone's watching. They come equipped with two-way audio and quick replies that can hold brief conversations, and if visitors recognize a video doorbell, they probably know it's already sent alerts to the owner about front door activity. Those qualities make doorbells an excellent method to deter porch pirates and other troublemakers. We also recommend planning for video storage so you have a way to save and download or share video clips when necessary. 4. Use alerts to call an audible Two-way audio features also let you call out trespassers. Ring/Amazon All the top home security cams now come with two-way audio features, which are one of the most effective deterrents if you notice something is wrong. Nothing can scare away a trespasser quite like the owner flipping on the speaker and calling out, "HEY! What are you doing?!" Plus, if it's just a very lost postman, you can always apologize afterward without getting the police involved. Two-way audio works well with timely camera alerts on your phone and object recognition so the alerts specify that a human was detected. 5. Set up sirens on home security devices Arming a system with a siren is a great way to scare off trespassers if they get too close. Kangaroo They aren't quite as ubiquitous as two-way audio, but many cameras and most home security kits also include sirens. On today's smart devices you have the option to turn on sirens with the app, or set the siren to sound off when certain kinds of motion are detected and the system is armed. It's a quick addition you can activate during setup, even for the smallest cams like the Blink Mini 2. 6. Position access sensors on windows and backdoors A full security system can watch over multiple access points at once. Abode/Amazon Access sensors enable a bunch of the tips we listed above if someone actually enters your home. They send alerts that allow you to immediately look through live views from cameras, use two-way audio in a shouty way or sound off a siren/flip on a floodlight. If you're worried about burglars breaching points like these (especially if you've had it happen before), the top home security system kits include sensors for exactly these reasons. 7. Set vacation modes with smart lights and more Smart lights and vacation modes make your house seem occupied even when you're not around. Ry Crist/CNET Smart security systems and home cams have an additional feature to help make vacations easier: They have vacation modes and customizable away modes. You can pair these modes with smart lights and set an activity schedule that makes it look like people are still home when you're away. Vacation modes like these will turn lights on and off to mimic people getting home in the evening, waking up in the morning and other everyday activities. They can discourage thieves looking for empty homes that make easy targets, and give you extra peace of mind on long vacations. These modes also pair very well with cams that let you take a peek as long as you have a reliable internet connection and access sensors that tell you when something went wrong. 8. Keep your garage closed and locked Smart garage doors come in many forms, including retrofits, but they're an excellent way to keep garage doors closed and uninviting to prowling thieves. Chris Monroe/CNET Many burglaries are crimes of opportunity, and one opportunity that can easily attract thieves (and racoons) is a garage door that's been left open. Consider equipping your garage door with a smart door system that can automatically close the door for you, secure it and remind you if the door is left open for any reason. These smart garage doors are frequently backward-compatible with existing garages, especially newer models, but you should always check how they work before you buy a new system. 9. Equip your door with a smart lock Smart locks ensure you never forget to lock the front door. Lockly Forgetting to lock the front door isn't quite as noticeable as leaving the garage open, but it can still attract thieves, who won't be shy about rattling doorknobs to see if entry is easy. A smart lock is a simple, incredibly effective way to monitor your main entry and make sure it's always locked at the right times. Today's smart locks can auto-lock after a period of inactivity, or send you reminders that they're open, so you can make a judgment call yourself. They also come with ways to give friends and family temporary passes to use the lock with their own phones, and options to review your access history. 10. Use an active professional home-monitoring service Professional home monitoring gives you extra eyes on developing situations. SimpliSafe Consider adding professional home monitoring to your security system for the most complete protection. Professional monitoring allows agents to view their alerts and contact emergency responders if necessary, so you don't have to rely on your own notifications. These monitoring plans don't have to be exorbitantly expensive: Arlo's Secure Premium plan offers full family monitoring services for $25 per month. Take a look at SimpliSafe's Fast Protect plan, which offers guides that look at cam live views and use audio to ask questions, for around $30 per month. Monitoring plans can take your home security to the next level if you don't mind the extra expense. 11. Add a delivery lock box to your porch Package lock boxes are a very old solution to a very modern problem. Felikuk A package lock box is a very simple, very effective addition to your home that shuts down porch piracy entirely. It works a lot like public package drop-offs, with one area where delivery people can drop in a package, and a holding area only accessible to the owner via key or keypad. Thieves can't get inside at all. Advanced models like Loxx Boxx also give you app control, remote access and alerts about when you get a delivery. This could be the perfect deterrent if you have porch-pirate problems in your neighborhood and get packages frequently. What about guard dogs as a security bonus? Many sources suggest getting a guard dog as a home theft deterrent. We do not recommend getting a dog specifically for security purposes, even if they're effective. It's not very fun for the dog, and it's difficult to train one to be wary of the wrong kind of strangers (and not, say, cousin Jimmy who's never been to your home before). Also, dog attacks regularly lead to trespassers suing homeowners for their injuries, and some states have liability laws that can encourage such lawsuits. Since staying safe is already on your mind, you can check out our recommendations for the top DIY home security systems, as well as ways to save money like turning an old phone into a security cam. And if you live with roommates, you'll want to peruse our guide on the best tech to keep your own room safe.
Metro
22-07-2025
- Entertainment
- Metro
The 7 most disturbing Doctor Who episodes of all time
For six decades now, Doctor Who has disturbed and delighted audiences around the world with terrifying tales of evil aliens and malicious monsters. From devious Daleks to sinister Cybermen, the Whoniverse is crawling (sometimes literally) with horrors beyond most people's imagining. Yet the question is, what are the most disturbing Doctor Who episodes? Well, there are plenty of chilling tales from the Tardis that have forced audiences to hide behind the sofa. There are stories like The Satan Pit, The Ark in Space, and who could forget Blink? Honestly, I could spend days curating this list, so to make things easier, I've done things a little differently I've limited myself to the revived era (starting in 2005) and chosen one story (some of these are two-parters) from each Doctor's run. That means there's one entry for every Doctor from the Ninth to the Fifteenth, so you get as comprehensive a list as possible. Wake up to find news on your TV shows in your inbox every morning with Metro's TV Newsletter. Sign up to our newsletter and then select your show in the link we'll send you so we can get TV news tailored to you. So what are you waiting for? Here are the seven most disturbing Doctor Who episodes! The first truly scary episode of the revival era, this two-part story sees the Ninth Doctor (Christopher Eccleston) and Rose (Billie Piper) track a mysterious ship through time to London during The Blitz. While there, however, the pair learn there are things far more dangerous than German bombs awaiting them as a strange gas mask-wearing child prowls the ruins of the city, desperately searching for his mummy. There's a long history of body horror in the Whoniverse, but this was the first episode to marry those old ideas with modern effects. This leads to arguably the most chilling scene in all of Christopher Eccleston's run, where Doctor Constantine (Richard Wilson) painfully vomits up a gas mask as he loses his mind and body to the Empty Child's strange curse. Combine that with a genuinely creepy atmosphere, a razor-sharp script from Steven Moffat and some superb acting, and you've a recipe for a truly sinister story. Is it any wonder these two episodes won a 2006 Hugo Award? Only the Tenth Doctor (or any of the Doctor's incarnations, actually) could go on the sci-fi equivalent of a coach trip and end up in a life-or-death situation. Yes, it might sound ridiculous, but this terrifying tale sees the Last of the Time Lords go on a solo adventure where he comes face to face with an impossible creature that slowly turns a coach-load of tourists against the Doctor (David Tennant). People may be surprised to see I've listed Midnight here and not Blink, but honestly, I think this is the scarier story. Why? Well, Midnight is a story where the Doctor's most powerful weapons, his wit, words and wonderful brain are all turned against him. As the mysterious creature grows in power, it takes more and more of him, leaving him an empty husk. It's only through sheer dumb luck that he manages to save the day, and it's a story that demonstrates in a universe full of Daleks, Cybermen, and Weeping Angels, there's no creature more dangerous than a frightened human. An underrated gem, The Girl Who Waited begins with the Eleventh Doctor (Matt Smith), Rory Williams (Arthur Darvill) and Amy Pond (Karen Gillan) landing on the resort world of Apalapucia. What should be a relaxing break becomes a nightmare, though, when Amy is trapped in a faster time stream and the Doctor and Rory are forced to watch Amy grow older and older with no way to help her. What makes The Girl Who Waited such a disturbing episode isn't its villain or the monster. It's that it uses time travel to tell a really effective story about Amy's fears and anxieties while exploring a moral dilemma that even the Doctor can't talk his way out of. Indeed, the final moments of the episode, where our hero betrays and kills Amy (although not the one we know… it's all a bit timey wimey), is one of the darkest moments in the series' history. When the Twelfth Doctor (Peter Capaldi), Master (Michelle Gomez) and Bill (Pearl Mackie) investigate a distress call in deep space, they discover a ship trapped in the event horizon of a black hole. That might sound dangerous enough, but things take an even darker turn when the crew gun down Bill, and she's taken away by mysterious patients who claim they heal Bill… more than that, they can make her better than new, whether she likes it or not. I'll be honest, I never found the new Cybermen that scary. They looked too much like robots, so it was easy to think of them as cybernetic automata. This two-parter, however, exposes the sheer horror of Cyber conversion by letting you see the human under the steel, a powerful and terrifying reminder that Cybermen are people who have had their humanity ripped away from them. This, coupled with the revelation that the Cybermen are and always have been the Mondasians (and potentially humanity's) ultimate destiny, is such a horrifying reveal that it gives me chills just thinking about it. The Power of the Doctor is the Thirteenth Doctor's (Jodie Whittaker) final story and sees The Daleks, The Cybermen and Rasputin (yes, really) team up to defeat the Doctor once and for all. Okay, I thought long and hard about which of Jodie's episodes to include, and it really came down to two episodes: this and Village of the Angels. Ultimately, though, I decided that there' something far more disturbing about this story for one specific reason. You see, so often the Doctor's enemies just want the Time Lord dead… or as dead as an immortal alien can be. Here, though, the plan is to change the Doctor permanently by forcing her to regenerate into The Master, effectively trapping them in their own body for all eternity. That's such a horrifying thought to have – not to mention the subtext of a man taking a woman's body without her permission – that I thought it had to be included on this list even if it's not as 'scary' as the other stories I chose to include here. After Donna (Catherine Tate) spills coffee on the Tardis controls, she and the Fourteenth Doctor (David Tennant… again) are flung to the edge of the universe, where they encounter an abandoned ship. As the duo explore the mysterious vessel, however, they quickly learn the ship might not be as abandoned as they thought. Wild Blue Yonder is a deliberately weird episode that makes brilliant use of the uncanny to unsettle viewers and leave them reaching for a sofa cushion to hide behind. Arguably, though, what makes this episode so effective is that we learn almost nothing about the 'Not-Things' that haunt the ship, with even the normally borderline omniscient Doctor baffled by where they came from and what they wanted. After all, what's scarier than the unknown? When the Fifteenth Doctor (Ncuti Gatwa) accidentally steps inside a fairy circle, he mysteriously disappears, leaving his companion Ruby (Millie Gibson) all alone. Well, not quite all alone. More Trending Everywhere Ruby goes, she's followed by a strange woman who's always 73 yards away and seems to terrify anyone who talks to her. The Fifteenth Doctor's era leaned into the supernatural and mystical more than other seasons of New Who. It's fitting then that its scariest episode is effectively an old-fashioned ghost story that relies more on an unsettling atmosphere and haunting visuals than big, bombastic scares to frighten you. Doctor Who is available to stream now on BBC iPlayer. Got a story? If you've got a celebrity story, video or pictures get in touch with the entertainment team by emailing us celebtips@ calling 020 3615 2145 or by visiting our Submit Stuff page – we'd love to hear from you. View More » MORE: Major stars and Hollywood icons who've appeared in Casualty from Tom Hiddleston to Kate Winslet MORE: Doctor Who legend takes swipe at 'grumpy old fans' of BBC series MORE: Ncuti Gatwa reveals real reason why he was replaced at Eurovision 2025
